Burkitt's lymphoma: remissions following seemingly non-specific therapy.
Long-term remissions observed in four out of eight unselected patients with Burkitt's lymphoma following seemingly non-specific treatment with Septicemine, are described. This is regarded as strong evidence of an effective immunological response.
D000293:Adolescent; D002051:Burkitt Lymphoma / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008441:Maxillary Neoplasms / Q000473:pathology; D008709:Methenamine / Q000008:administration & dosage / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local; D009365:Neoplasm Regression, Spontaneous; D009918:Orbital Neoplasms / Q000473:pathology
D008709:Methenamine